Global Prenatal Testing Market Report, 2023-2024 and 2028: Increase in Down Syndrome and Rare Genetic Disorders, Increasing Maternal Age, and Advancements in Technology Driving Growth

Global Prenatal Testing Market Report, 2023-2024 and 2028: Increase in Down Syndrome and Rare Genetic Disorders, Increasing Maternal Age, and Advancements in Technology Driving Growth

GlobeNewswire

Published

Dublin, May 01, 2024 (GLOBE NEWSWIRE) -- The "Global Prenatal Testing Market 2023-2028" report has been added to * ResearchAndMarkets.com's* offering.

The global market for prenatal testing is expected to grow from $10.9 billion in 2023 and is projected to reach $19.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 12.6% during the forecast period of 2023 to 2028.

The scope of the prenatal testing market is extensive and continually evolving, reflecting the dynamic landscape of technologies and methodologies employed to assess fetal health during pregnancy.

Genetic testing plays a central role, encompassing a range of approaches from traditional invasive procedures, such as amniocentesis and chorionic villus sampling to modern noninvasive methods, such as noninvasive prenatal testing (NIPT). This market is characterized by its global reach, with varying levels of adoption and accessibility across different regions.

The focus is predominantly on screening for genetic disorders, including chromosomal abnormalities and hereditary conditions. The rise of comprehensive testing strategies evaluating multiple biomarkers enhances diagnostic accuracy. The market is driven by increasing maternal age, heightened awareness of genetic disorders and technological advancements.

Ongoing research and development (R&D) efforts continue to shape the scope of prenatal testing, with a strong emphasis on improving accuracy and accessibility and incorporating innovative diagnostic and screening procedures. It presents insights into current and future potential, drivers, challenges, opportunities, industry status, developments, market trends, geographical challenges and strategies (e.g., mergers, acquisitions, collaborations).

The report informs all market players, potential entrants, government agencies and other interested parties. The report covers geographic regions in detail, so companies interested in expanding their geographic reach will also find this helpful study.

*Report Includes*

· 37 data tables and 52 additional tables
· An overview of the current and future global markets for prenatal testing
· Analyses of global market trends, with historical revenue data (sales figures) for 2021-2022, estimates for 2023, forecasts for 2024, and projected CAGRs through 2028
· Estimates of the current market size and revenue growth prospects, along with a market share analysis by technology and product types, application, end users and region
· Discussion of the market opportunities and challenges, ongoing R&D efforts and regulatory scenarios
· A look at emerging technologies related to prenatal testing
· Overview of the sustainability trends and ESG developments, with emphasis on consumer attitudes, companies' ESG rankings and their ESG practices
· Insight into the competitive landscape, including company market shares, financials and revenues
· Profiles of the leading players, including Illumina Inc., Laboratory Corporation of America Holdings, Thermo Fisher Scientific Inc., Natera Inc., and F. Hoffmann-La Roche Ltd.

*Company Profiles*

· 10X Genomics
· Agilent Technologies Inc.
· BGI
· Eurofins Scientific
· F. Hoffmann-La Roche Ltd.
· Illumina Inc.
· Laboratory Corporation Of America Holdings
· Medicover Genetics
· Natera Inc.
· Qiagen
· Quest Diagnostics Inc.
· Revvity Inc.
· Thermo Fisher Scientific Inc.
· Yourgene Health

*Key Attributes:*

*Report Attribute* *Details*
No. of Pages 134
Forecast Period 2023 - 2028
Estimated Market Value (USD) in 2023 $10.9 Billion
Forecasted Market Value (USD) by 2028 $19.8 Billion
Compound Annual Growth Rate 12.6%
*Key Topics Covered:*

*Chapter 1 Executive Summary*

· Market Outlook
· Scope of Report
· Market Summary

*Chapter 2 Market Overview*

· Prenatal Testing
· History of Prenatal Testing
· Most Common Chromosomal Abnormalities
· Down Syndrome
· Trisomy 13 and Trisomy 18
· Sex Chromosome Differences
· Neural Tube Defects
· Noninvasive Techniques
· Noninvasive Prenatal Test/Cell-Free DNA Screening
· Maternal Serum Screening Test
· Ultrasound Testing
· Others
· Invasive Techniques
· Chorionic Villus Sampling
· Amniocentesis

*Chapter 3 Market Dynamics*

· Factors Affecting the Prenatal Testing Market
· Market Drivers
· Increase in Down Syndrome
· Increase in Rare Genetic Disorders
· Increasing Maternal Age
· Advancements in Technology
· Restraints
· High Cost of Testing
· False Positives and Negatives Results
· Future Opportunities
· Expanding Applications
· Emerging Markets
· Personalized Medicine
· Challenges
· Regulatory Hurdles
· Public Perception
· Noninvasive Prenatal Testing Coverage Challenges: Policy Disparities

*Chapter 4 Emerging and Upcoming Technologies in the Market*

· Introduction
· Enhancing Copy Number Variation Detection Through Whole-Genome Sequencing
· Single Nucleotide Polymorphisms Analysis
· Whole-Exome Sequencing
· Advanced Imaging Techniques
· Liquid Biopsy for Cancer Detection
· Artificial Intelligence in Prenatal Testing

*Chapter 5 Market Segmentation Analysis*

· Segmentation by Product Type
· Market Size
· Consumables
· Instruments
· Segmentation by Technology
· Overview
· Market Share
· Noninvasive Techniques
· Invasive Techniques
· Segmentation by Application
· Overview
· Market Share
· Neural Tube Defects
· Down Syndrome
· Rare Genetic Disorders
· Others
· Segmentation by End User
· Overview
· Market Share
· Diagnostic Laboratories
· Hospitals
· Geographic Breakdown
· Overview
· North America
· Europe
· Asia-Pacific
· Rest of the World

*Chapter 6 Competitive Landscape*

· Mergers, Acquisitions and Collaborations
· Prenatal Testing Manufacturers and Service Providers Market Shares
· Patent Review and New Developments
· Overview
· Patent Analysis by Year

*Chapter 7 ESG Development*

· Introduction
· Sustainability of Prenatal Testing in Industry

*Chapter 8 Appendix*

· Methodology
· Intended Audience
· Abbreviations
· Sources

For more information about this report visit https://www.researchandmarkets.com/r/lch0pl

*About ResearchAndMarkets.com*
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

*Attachment*

· Global Prenatal Testing Market

CONTACT: CONTACT: ResearchAndMarkets.com
Laura Wood,Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Full Article